David E. Cohn, MD
Professor
The Ohio State University
320 West 10th Avenue
M-210 Starling Loving Hall
Columbus,
OH
USA
43210
Biographical Sketch: I direct the division of a PPS-exempt cancer hospital, and am a member of the SGO Quality and Outcomes Committee"
Papers:
5 - Scientific Plenary
A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research
6 - Scientific Plenary
Evaluation of incidence and prognostic significance of newly identified hotspot mutations in DNA polymerase epsilon (POLE) in endometrial cancer: contextualizing findings from The Cancer Genome Atlas Research Network
393 - Poster Session B
Risk of complications after robotic hysterectomy for endometrial cancer in obese patients with preoperative comorbidities
402 - Poster Session B
Bariatric surgery of a means to decrease mortality in women with type I endometrial cancer: an intriguing option in a population at risk for dying of complications of metabolic syndrome
408 - Poster Session B
A prospective, randomized trial on the impact of patient navigation in women with abnormal cervical cytology
415 - Poster Session B
Body mass index (BMI) associations, including mismatch repair protein expression, in 1,051 endometrial carcinomas
516 - Poster Session B
Outpatient rapid desensitization for gynecologic oncology patients with mild to moderate hypersensitivity reactions to platinums
Debate: Costs and Quality of Life: Anti Angiogenesis Agents Should be reserved for patients with Platinum Resistant Disease